Creative Medical Technology Holdings, Inc. (CELZ)

NASDAQ: CELZ · IEX Real-Time Price · USD
0.522
-0.030 (-5.52%)
At close: Feb 3, 2023, 4:00 PM
0.500
-0.022 (-4.23%)
After-hours: Feb 3, 2023, 5:58 PM EST
-5.52%
Market Cap 7.35M
Revenue (ttm) 137,754
Net Income (ttm) -7.80M
Shares Out 14.08M
EPS (ttm) -4.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 183,824
Open 0.570
Previous Close 0.553
Day's Range 0.498 - 0.570
52-Week Range 0.330 - 5.145
Beta 4.90
Analysts Buy
Price Target 10.20 (+1,853.65%)
Earnings Date n/a

About CELZ

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 4
Stock Exchange NASDAQ
Ticker Symbol CELZ
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for CELZ stock is "Buy." The 12-month stock price forecast is $10.2, which is an increase of 1,853.65% from the latest price.

Price Target
$10.2
(1,853.65% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes

AlloStem™ represents the first novel allogenic cellular therapy in the dorsal artery of the pancreas in the United States   PHOENIX , Nov. 3, 2022 /PRNewswire/ -- Creative Medical Technology Holdings,...

3 months ago - PRNewsWire

Creative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line

PHOENIX , Oct. 20, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, ...

3 months ago - PRNewsWire

Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study

--Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients who Underwent the StemSpine® Procedure for Treating Chronic Lower Back Pain -- PHOENIX , Sept. 26, ...

4 months ago - PRNewsWire

Creative Medical Technology Announces Positive Top-Line Results for OvaStem® Pilot Study

Three-Year Follow Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients receiving OvaStem® Procedure for Treating Primary Ovarian Insufficiency PHOENIX , July 28, 2022 /PR...

6 months ago - PRNewsWire

Creative Medical Technology Holdings Announces Agreement with Greenstone Biosciences, Inc. for Development of a Next Generation iPSC Pipeline for its ImmCelz® Immunotherapy Platform

PHOENIX , June 15, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company foc...

8 months ago - PRNewsWire

Creative Medical Technology Announces $17 Million Private Placement Priced At-The-Market Under Nasdaq Rules

PHOENIX , April 29, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company fo...

10 months ago - PRNewsWire

Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company's ImmCelz® Product

-- Initial experiments demonstrate expeditious potential for high-volume production of ImmCelz® with consistent potency -- PHOENIX , April 20, 2022 /PRNewswire/ -- Creative Medical Technology Holdings...

10 months ago - PRNewsWire

Creative Medical Technology to Showcase CaverStem® at American Urological Association Annual Meeting - Largest and Most Prominent Gathering of Urologists in the World

PHOENIX , April 12, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company fo...

10 months ago - PRNewsWire

Creative Medical (CELZ) Up 82% on Stem Cell Treatment Data

Creative Medical Technology (CELZ) reports positive follow-up data from a pilot study evaluating StemSpine, a patented stem cell treatment for chronic lower back pain.

11 months ago - Zacks Investment Research

Why Is Creative Medical Technology (CELZ) Stock Up Today?

Creative Medical Technology announced positive results concerning its StemSpine procedure. Here's what you should know as CELZ stock rises.

11 months ago - InvestorPlace

Why Creative Medical Technology Shares Are Soaring

Creative Medical Technology Holdings Inc (NASDAQ: CELZ) shares are trading higher Wednesday after the company announced top-line results for its follow-up StemSpine pilot study. The initial study show...

11 months ago - Benzinga

Creative Medical Shares Soar On Positive Data from StemSpine Pilot Study

Creative Medical Technology Holdings (NASDAQ: CELZ) has announced positive two-year follow-up data from its StemSpine pilot study.

11 months ago - Benzinga

Creative Medical Technology Announces Positive Top-Line Results for StemSpine® Pilot Study

--Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients Using StemSpine® Procedure for Treating Chronic Lower Back Pain -- PHOENIX, March 23, 2022 /PRNewsw...

11 months ago - PRNewsWire

Creative Medical Technology to Participate in the 34th Annual Roth Conference

PHOENIX, March 8, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focu...

11 months ago - PRNewsWire

Creative Medical Technology Appoints Sahil Nock as Chief Commercial Officer

PHOENIX, Ariz. , March 2, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology comp...

1 year ago - PRNewsWire

8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE

We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading. The post 8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, ...

Other symbols: AUVIGNPXPTEWAVE
1 year ago - InvestorPlace

CELZ Stock: 5 Things to Know About Trending Penny Stock Creative Medical Technology

Creative Medical Technology (CELZ) stock is taking off on Monday despite a lack of news from the commercial-stage biotechnology company. The post CELZ Stock: 5 Things to Know About Trending Penny Stoc...

1 year ago - InvestorPlace

Creative Medical Technology Holdings, Inc. Prices $16 Million Public Offering and Uplisting to the Nasdaq Capital Market

PHOENIX, Dec. 3, 2021 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (the "Company") (NASDAQ: CELZ), a commercial stage biotechnology company focused on a regenerative approach to Immunoth...

1 year ago - PRNewsWire

Creative Medical Technology Holdings Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to The Nasdaq Capital Market

PHOENIX, Nov. 9, 2021 /PRNewswire/ -- (OTC-CELZ) Creative Medical Technology Holdings, Inc. (the "Company"), a commercial stage biotechnology company focused on immunology, urology, neurology and orth...

1 year ago - PRNewsWire